Officiële publicaties OSE Immunotherapeutics

Aandelen

Beurs gesloten - Euronext Paris Andere beurzen 17:36:04 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,2 ^EUR	-0,64%		+11,51%	+44,86%

16/04	De wereldwijde licentie van OSE Immunotherapeutics SA voor de ontwikkeling van een nieuw monoklonaal antilichaam voor de behandeling van chronische ontstekingen wordt effectief	CI
27/03	OSE Immunotherapeutics SA rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Universal registration document	02/05	CO
Monthly statement on voting rights	03/04	CO
Annual results	27/03	CO
Annual results	27/03	CO
Monthly statement on voting rights	29/02	CO
Threshold crossings	06/02	CO
Security operations	06/02	CO
Monthly statement on voting rights	31/01	CO
Threshold crossings	09/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	31-10-23	CO
Monthly statement on voting rights	30-09-23	CO
1st-half-year results	27-09-23	CO
Half-year report	27-09-23	CO
Monthly statement on voting rights	31-08-23	CO
Monthly statement on voting rights	30-06-23	CO
Shareholders meeting voting results	22-06-23	CO
Monthly statement on voting rights	31-05-23	CO
Mixed general Shareholders meeting notice	15-05-23	CO
Monthly statement on voting rights	30-04-23	CO
Auditors Report	28-04-23	CO
Universal registration document	28-04-23	CO
Monthly statement on voting rights	31-03-23	CO
Monthly statement on voting rights	28-02-23	CO